Assessment of Anti–Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics

IMPORTANCE: Between 4% and 12% of patients undergoing colorectal surgery and receiving enoxaparin, 40 mg per day, have a postoperative venous thromboembolism (VTE) event. An improved understanding of why “breakthrough” VTE events occur despite guideline-compliant prophylaxis is an important patient...

詳細記述

保存先:
書誌詳細
出版年:JAMA Surg
主要な著者: Pannucci, Christopher J., Fleming, Kory I., Bertolaccini, Corinne B., Prazak, Ann Marie, Huang, Lyen C., Pickron, T. Bartley
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2019
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537829/
https://ncbi.nlm.nih.gov/pubmed/31116389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2019.1165
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料